Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

HYPR stock hub

Hyperfine, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

HYPRis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
166.5M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
HYPR
In the news

Latest news · HYPR

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-79
P25 -105.6P50 -46.5P75 -3.1
ROIC-51.1
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All HYPR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
205
Groups with data
11
Currency
USD
Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

24
MetricValue
Cik
0001833769
Company name
Hyperfine, Inc.
Country
United States
Country code
US
Cusip
44916K106
Employees
102
Employees Change
-9%
Employees Change Percent
-8.11
Enterprise value
$131.7M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Medical Devices
Isin
US44916K1060
Last refreshed
2026-05-10
Market cap
$166.5M
Market cap category
Micro-Cap
Price
$1.69
Price currency
USD
Rev Per Employee
132,970.59x
Sector
Healthcare
Sic
3845
Symbol
HYPR
Website
https://www.hyperfinemri.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-21.37%
EV Sales Forward
6.4x
EV/Sales
9.71x
FCF yield
-17.5%
P/B ratio
4.01x
P/S ratio
12.28x
PS Forward
8.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

19
MetricValue
EBIT Margin
-273.43%
EBITDA Margin
-265.39%
Gross margin
49.79%
Gross Profit
$6.8M
Gross Profit Growth
14.63%
Gross Profit Growth Q
226.15%
Gross Profit Growth3 Y
95.27%
Net Income
$-35.6M
Net Income Growth Quarters
1%
Net Income Growth Years
3%
Pretax Margin
-262.29%
Profit Margin
-262.29%
Profit Per Employee
$-348,765
ROA
-40.61
Roa5y
-31.86
ROCE
-85.19
ROE
-79.01
Roe5y
-56.19
ROIC
-51.11

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr1y
138.64%
Cagr3y
5%
Cagr5y
-29.86%
EPS Growth Quarters
1
EPS Growth Years
4
Revenue Growth
5.22x
Revenue Growth Q
128.05x
Revenue Growth Quarters
1x
Revenue Growth Years
5x
Revenue Growth3 Y
25.79x
Revenue Growth5 Y
115.18x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Asset Turnover
$0.24
Assets
$55.3M
Cash
$35.1M
Current Assets
$50.9M
Current Liabilities
$11.7M
Debt
$314,000
Debt Equity
$0.01
Equity
$41M
Liabilities
$14.3M
Long Term Assets
$4.4M
Long Term Liabilities
$2.5M
Net Cash
$34.8M
Net Cash By Market Cap
$20.88
Net Cash Growth
-6.78%
Net Debt Equity
$-0.85
Tangible Book Value
$41M
Tangible Book Value Per Share
$0.42
WACC
12.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
4.34
Inventory Turnover
1.05
Net Working Capital
$4.3M
Quick ratio
3.56
Working Capital
$39.2M
Working Capital Turnover
$0.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-12.96%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
1Y total return
138.5%
200-day SMA
1.22
3Y total return
15.75%
50-day SMA
1.27
50-day SMA vs 200-day SMA
50over200
5Y total return
-83.02%
All Time High
16.61
All Time High Change
-89.83%
All Time High Date
2021-12-23
All Time Low
0.53
All Time Low Change
217.25%
All Time Low Date
2025-05-23
ATR
0.12
Beta
1.42
Beta1y
0.96
Beta2y
1.1
Ch YTD
72.57
High
1.75
High52
2.22
High52 Date
2025-10-15
High52ch
-23.87%
Low
1.68
Low52
0.53
Low52 Date
2025-05-23
Low52ch
217.25%
Ma50ch
33.28%
Premarket Change Percent
0
Premarket Price
$1.68
Price vs 200-day SMA
38.18%
RSI
67.61
RSI Monthly
56.78
RSI Weekly
64.49
Sharpe ratio
1.3x
Sortino ratio
2.3
Total Return
-12.96%
Tr YTD
72.57
Tr1m
52.25%
Tr1w
-9.63%
Tr3m
53.64%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

9
MetricValue
Analyst Count
4
Analyst Ratings
Strong Buy
Earnings EPS Estimate
$-0.09
Earnings Revenue Estimate
3,508,000x
Earnings Revenue Estimate Growth
64.16x
Operating Income
$-37.1M
Operating margin
-273.4
Price target
$1.59
Price Target Change
$-5.92

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
79,435,948%
Float Percent
80.63%
Shares Insiders
16.83%
Shares Institutions
14.14%
Shares Out
98,520,197
Shares Qo Q
19.2%
Shares Yo Y
12.96%
Short Float
1.44%
Short Ratio
2.26
Short Shares
1.16

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

60
MetricValue
Adjusted FCF
$-31.9M
Average Volume
741,699x
Bv Per Share
0.42
CAPEX
$-1.2M
Ch1m
52.25
Ch1w
-9.63
Ch1y
138.5
Ch3m
53.64
Ch3y
15.75
Ch5y
-83.02
Ch6m
57.94
Change
0.6%
Change From Open
0
Close
1.68
Days Gap
0.6
Depreciation Amortization
1,090,000
Dollar Volume
598,491.5
Earnings Date
2026-05-12
Earnings Time
amc
EBIT
$-37.1M
EBITDA
$-36M
EPS
$-0.43
F Score
3
FCF
$-29.1M
FCF EV Yield
-22.12x
FCF Per Share
$-0.3
Financing CF
27,502,000
Fiscal Year End
December
Founded
2,014
Investing CF
-1,185,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-03-18
Last Report Date
2025-12-31
Last Split Type
Never
Last10k Filing Date
2026-03-18
Ma150
1.2
Ma150ch
40.37%
Ma20
1.45
Ma20ch
16.39%
Net CF
-1,631,000
Next Earnings Date
2026-05-12
Open
1.69
Optionable
Yes
Position In Range
20
Post Close
1.69
Postmarket Change Percent
2.37
Postmarket Price
$1.73
Ppne
2,865,000
Pre Close
1.68
Price Date
2026-05-08
Ptbv Ratio
4.06
Relative Volume
0.48x
Revenue
13,563,000x
SBC By Revenue
20.65x
Share Based Comp
2,801,000
Tr6m
57.94%
Us State
Connecticut
Volume
354,137
Z Score
-5.96
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does HYPR pay a dividend?

Capital-return profile for this ticker.

Performance

HYPR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+138.5%
S&P 500 1Y: n/a
3Y total return
+15.8%
S&P 500 3Y: n/a
5Y total return
-83.0%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns HYPR?

Insider, institutional, and short-interest positioning.

Institutional ownership
+14.1%
Float: +80.6% of shares outstanding
Insider ownership
+16.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+1.4%
2.3 days to cover
Y/Y dilution
+13.0%
Negative means the company is buying back shares.
Technical

HYPR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
67.6
Neutral momentum band
Price vs 200-day MA
+38.2%
50/200-day relationship not available
Beta (5Y)
1.42
More volatile than the market
Sharpe ratio
1.30
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About HYPR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current HYPR stock rating?

Hyperfine, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full HYPR analysis?

The full report lives at /stocks/HYPR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for HYPR?

The latest report frames HYPR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the HYPR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.